Securities

Deadline Alert: Rosen Law Firm Reminds Edwards Lifesciences Investors of Upcoming Lead Plaintiff Deadline in Securities Class Action Lawsuit

by

NEW YORK — Rosen Law Firm, renowned for championing global investor rights, has issued a reminder about the impending lead plaintiff deadline of December 13, 2024, for those who acquired securities from Edwards Lifesciences Corporation during the period of February 6, 2024, to July 24, 2024. This deadline is crucial for investors who believe they have suffered losses due to potential misinformation by Edwards Lifesciences regarding their financial forecasts and product performance. Investors who have bought Edwards securities within this specified period may be eligible for compensation without the necessity of any out-of-pocket fees or … Read more

LILM, LILMF Investors Invited to Spearhead Securities Fraud Class Action Against Lilium N.V.

by

Investors in Lilium N.V., a prominent aerospace company specializing in electric vertical take-off and landing (eVTOL) aircraft, have been presented with the chance to lead a securities fraud lawsuit against the firm. The case emerges as allegations surface about possible misleading information provided by Lilium that might have led to investment losses. Lilium, known for its pioneering work in sustainable aviation, aimed to transform urban mobility through its innovative vehicle designs. However, recent claims suggest that the company may have been overly optimistic about the technical viability and commercial readiness of its jet prototypes. The … Read more

GitLab Faces Securities Class Action: Investors Alerted to Join Lawsuit Over Alleged Misleading AI Development Claims

by

Los Angeles, California – The Schall Law Firm, recognized for representing shareholder rights in national litigation, has recently announced a class action lawsuit targeting GitLab Inc. (NASDAQ: GTLB). The suit accuses the company of violations related to the Securities Exchange Act of 1934, specifically under sections 10(b) and 20(a), along with Rule 10b-5, as put forth by the U.S. Securities and Exchange Commission. This litigation comes following allegations that GitLab disseminated misleading information about its capabilities, particularly concerning its development of artificial intelligence tools aimed at bolstering its DevSecOps platform. The firm prompts investors who … Read more

Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13

by

New York — Investors who purchased securities from Edwards Lifesciences Corporation between February 6, 2024, and July 24, 2024, are potentially eligible for compensation, as announced by Rosen Law Firm, a global investor rights legal practice. The firm, which focuses on securities class actions and shareholder derivative litigation, has set a lead plaintiff deadline of December 13, 2024. Anyone who acquired shares in Edwards Lifesciences during the said period might take part in the class action lawsuit without any out-of-pocket fees, as the costs are covered by a contingency fee arrangement. Those interested in joining … Read more